Skip to main content
SpringerLink
Log in

Investigating the demographic characteristics and pathological manifestations of thyroid Cancer during the last two decades (1997–2017) in patients referred to Baqiyatallah hospital, Tehran, Iran

  • Research article
  • Published:
Journal of Diabetes & Metabolic Disorders Aims and scope Submit manuscript

Abstract

Background & Objective

Thyroid cancer is among the most common endocrine cancers, and its incidence in our country is in progress over the past decades. This aggravates the necessity to evaluate the changes in thyroid cancer.

Materials & methods

Through accessing the information of the records of all patients with a diagnosis of thyroid cancer between 1996 and 2017, the present study was conducted at Baqiyatallah Hospital (Tehran, Iran) according to scientific criteria. After the diagnosis, most of them also underwent surgery and were evaluated in terms of the rate of the involvement and the type of thyroid cancer, and the pathology report was recorded in their records. Information about the intended patients such as age, gender, pathologic type of cancer, associated with the patient (except thyroid cancer), and history of radiation to the patient were recorded in a standard form and subjected to statistical analysis. Demographic changes and pathological manifestations of cancers in the two decades (1997–2007) and (2007–2017) were compared. But comparisons have been made over five years.

Results

The incidence of thyroid cancer, especially papillary thyroid cancer type, was increasing at an early age, and the incidence of tumor size measuring 2–4 cm was rising. But the incidence of tumor sizes less than one centimeter declined. The amount of vascular and capsule involvement was about 3 times, and lymph node involvement was nearly 2 times. The increasing incidence of 2–4 cm tumor size in the age group of 20–50 years was more than other age groups.

Conclusion

The incidence of thyroid cancer was increasing at an early age, and the enhancement of papillary thyroid type was higher than other types. As well as, in this study, it was found that the incidence of 2–4 cm tumor sizes was rising.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Chart 1
Chart 2
Chart 3
Chart 4

Similar content being viewed by others

References

  1. Gianfranco Alicandro, Carlo La Vecchi. Occupational Exposures and Thyroid Cancer. Occupational Cancers pp 525–541. https://doi.org/10.1007/978-3-030-30766-0_30#citeas.

  2. Ancker OV, Krüger M, Wehland M, Infanger M, Grimm D. Review Multikinase Inhibitor Treatment in Thyroid Cancer. Int. J. Mol. Sci. 2020;21:10.

    Article  CAS  Google Scholar 

  3. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid Cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid Cancer. Thyroid. 2016;26(1):1–133.

    Article  Google Scholar 

  4. Yeh MW, Bauer AJ, Bernet VA, et al. American thyroid association statement on preoperative imaging for thyroid cancer surgery. Thyroid. 2015;25(1):3–14.

    Article  Google Scholar 

  5. Tufano RP, Clayman G, Heller KS, Inabnet WB, Kebebew E, Shaha A, et al. Management of recurrent / persistent nodal disease in patients with differentiated thyroid cancer: a critical review of the risks and benefits of surgical intervention versus active surveillance. Thyroid. 2015;25(1):15–27.

    Article  Google Scholar 

  6. Dal Maso L, Tavilla A, Pacini F, et al. Survival of 86,690 patients with thyroid cancer: A population-based study in 29 European countries from EUROCARE-5. Eur J Cancer. 2017;77:140–52.

    Article  CAS  Google Scholar 

  7. Weir HK, Thompson TD, Soman A, et al. The past, present, and future of cancer incidence in the United States: 1975 through 2020. Cancer. 2015 Feb 3.

  8. Davies L, Welch HG. Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg. 2014;140(4):317–22.

    Article  Google Scholar 

  9. Morris LG, Sikora AG, Tosteson TD, Davies L. The increasing incidence of thyroid cancer: the influence of access to care. Thyroid. 2013;23(7):885.

    Article  Google Scholar 

  10. Le KT, Sawicki MP, Wang MB, Hershman JM, Leung Am. High prevalence of agent Orange exposure among thyroid Cancer patients in the National Va Healthcare System. EndocrPract. 2016; 27.

  11. Brito JP, Morris JC, Montori VM. Thyroid cancer: zealous imaging has increased detection and treatment of low risk tumours. BMJ. 2013;347:f4706 [Medline].

    Article  Google Scholar 

  12. Asari R, Koperek O, Scheuba C, Riss P, Kaserer K, Hoffmann M. Follicular thyroid carcinoma in an iodine-replete endemic goiter region: a prospectively collected, retrospectively analyzed clinical trial. Ann Surg. 2009;249(6):1023–31 [Medline].

    Article  Google Scholar 

  13. Nixon IJ, Ganly I, Patel SG, Palmer FL, Di Lorenzo MM, Grewal RK, et al. The results of selective use of radioactive iodine on survival and on recurrence in the management of papillary thyroid cancer, based on memorial sloan-kettering cancer center risk group stratification. Thyroid. 2013;23(6):683–94 [Medline].

    Article  CAS  Google Scholar 

  14. Chen AY, Jemal A, Ward EM. Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer. 2009;115(16):3801–7.

    Article  Google Scholar 

  15. Aschebrook-Kilfoy B, Grogan RH, Ward MH, Kaplan E, Devesa SS. Follicular thyroid cancer incidence patterns in the United States, 1980-2009. Thyroid. 2013;23(8):1015–21.

    Article  Google Scholar 

  16. Pellegriti G, Frasca F, Regalbuto C, Squatrito S, Vigneri R. Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. Journal of cancer epidemiology. 2013;2013:1–10.

    Article  Google Scholar 

  17. Larijani B, Aghakhani S, Khajeh-Dini H, Baradar-Jalili R. Clinico-pathological features of thyroid cancer as observed in five referral hospitals in Iran. ActaOncologica. 2003;42(4):334–7.

    Google Scholar 

  18. Haghpanah V, Soliemanpour B, Heshmat R, Mosavi-Jarrahi AR, Tavangar SM, Malekzadeh R, et al. Endocrine cancer in Iran: based on cancer registry system. Indian J Cancer. 2006;43(2):80.

    Article  CAS  Google Scholar 

  19. Pandeya N, McLeod DS, Balasubramaniam K, Baade PD, Youl PH, Bain CJ, et al. Increasing thyroid cancer incidence in Queensland, Australia 1982-2008-true increase or overdiagnosis ? Clin Endocrinol. 2016;84(2):257–64.

    Article  CAS  Google Scholar 

  20. Larijani B, Aghakhani S, Haghpanah V, Mosavi-Jarrahi A, Bastanhagh MH. Review of thyroid Cancer in Iran. Austral-Asian Journal of Cancer. 2005;4(4):199–203.

    Google Scholar 

  21. Enewold L, Zhu K, Ron E, Marrogi AJ, Stojadinovic A, Peoples GE, et al. Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. Cancer Epidemiol Biomark Prev. 2009;18(3):784–91.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Baqiyatallah University of Medical Sciences, Tehran, Iran

    Majid Ramezani & Mahmoud Hasani

  2. Otorhinolaryngology Department, Baqiyatallah University of Medical Sciences, Tehran, Iran

    Masoumeh Saeidi

  3. Department of Physiology, Shiraz University of Medical Sciences, Shiraz, Iran

    Ali Zarei

Authors
  1. Majid Ramezani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Masoumeh Saeidi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ali Zarei
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mahmoud Hasani
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Majid Ramezani.

Ethics declarations

Conflict of interest

The authors declared that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ramezani, M., Saeidi, M., Zarei, A. et al. Investigating the demographic characteristics and pathological manifestations of thyroid Cancer during the last two decades (1997–2017) in patients referred to Baqiyatallah hospital, Tehran, Iran. J Diabetes Metab Disord 19, 1165–1172 (2020). https://doi.org/10.1007/s40200-020-00617-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40200-020-00617-x

Keywords

Search

Navigation